37 related articles for article (PubMed ID: 30041555)
1. The role of Matrix Metalloproteinase-2 and Galectin-3 as predictive biomarkers for all-cause mortality in patients undergoing transfemoral transcatheter aortic valve implantation.
Piayda K; Heilemann JT; Keranov S; Schulz L; Arsalan M; Liebetrau C; Kim WK; Hofmann FJ; Bauer P; Voss S; Troidl C; Sossalla ST; Hamm CW; Nef HM; Dörr O
Biomarkers; 2024 Jun; 29(4):205-210. PubMed ID: 38588595
[TBL] [Abstract][Full Text] [Related]
2. Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI.
Azam TU; Shadid HR; Blakely P; O'Hayer P; Berlin H; Pan M; Zhao P; Zhao L; Pennathur S; Pop-Busui R; Altintas I; Tingleff J; Stauning MA; Andersen O; Adami ME; Solomonidi N; Tsilika M; Tober-Lau P; Arnaoutoglou E; Keitel V; Tacke F; Chalkias A; Loosen SH; Giamarellos-Bourboulis EJ; Eugen-Olsen J; Reiser J; Hayek SS;
J Am Soc Nephrol; 2020 Nov; 31(11):2725-2735. PubMed ID: 32963090
[TBL] [Abstract][Full Text] [Related]
3. Soluble urokinase receptor as a predictor of non-cardiac mortality in patients with percutaneous coronary intervention treated ST-segment elevation myocardial infarction.
Sandø A; Schultz M; Eugen-Olsen J; Køber L; Engstrøm T; Kelbæk H; Jørgensen E; Saunamäki K; Holmvang L; Pedersen F; Tilsted HH; Høfsten D; Helqvist S; Clemmensen P; Iversen K
Clin Biochem; 2020 Jun; 80():8-13. PubMed ID: 32213303
[TBL] [Abstract][Full Text] [Related]
4. Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls.
Jirak P; Pistulli R; Lichtenauer M; Wernly B; Paar V; Motloch LJ; Rezar R; Jung C; Hoppe UC; Schulze PC; Kretzschmar D; Braun-Dullaeus RC; Bekfani T
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32326570
[TBL] [Abstract][Full Text] [Related]
5. Reproducibility of novel immune-inflammatory biomarkers over 4 months: an analysis with repeated measures design.
Schenk M; Eichelmann F; Schulze MB; Rudovich N; Pfeiffer AF; di Giuseppe R; Boeing H; Aleksandrova K
Biomark Med; 2019 Jun; 13(8):639-648. PubMed ID: 31157547
[No Abstract] [Full Text] [Related]
6. Predictive value of soluble urokinase-type plasminogen activator receptor for mortality in patients with suspected myocardial infarction.
Sörensen NA; Nikorowitsch J; Neumann JT; Rübsamen N; Goßling A; Hartikainen TS; Blankenberg S; Westermann D; Zeller T; Karakas M
Clin Res Cardiol; 2019 Dec; 108(12):1386-1393. PubMed ID: 30989318
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Addition to High-Sensitivity Troponin I in Early Diagnosis of Acute Myocardial Infarction.
Sörensen NA; Dönmez G; Neumann JT; Nikorowitsch J; Rübsamen N; Blankenberg S; Westermann D; Zeller T; Karakas M
Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30889909
[TBL] [Abstract][Full Text] [Related]
8. Soluble urokinase plasminogen activation receptor and long-term outcomes in persons undergoing coronary angiography.
Sommerer C; Zeier M; Morath C; Reiser J; Scharnagl H; Stojakovic T; Delgado GE; März W; Kleber ME
Sci Rep; 2019 Jan; 9(1):475. PubMed ID: 30679668
[TBL] [Abstract][Full Text] [Related]
9. A Story of PA/BSA and Biomarkers to Diagnose Pulmonary Hypertension in Patients with Severe Aortic Valve Stenosis-The Rise of IGF-BP2 and GDF-15.
Kletzer J; Hecht S; Ramsauer S; Scharinger B; Kaufmann R; Kammler J; Kellermair J; Akbari K; Blessberger H; Steinwender C; Hergan K; Hoppe UC; Lichtenauer M; Boxhammer E
J Cardiovasc Dev Dis; 2023 Jan; 10(1):. PubMed ID: 36661917
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future.
Omran F; Kyrou I; Osman F; Lim VG; Randeva HS; Chatha K
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628490
[TBL] [Abstract][Full Text] [Related]
11. Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Systematic Review of Non-Invasive Ways of Risk Stratification, Especially in Patients Undergoing Transcatheter Aortic Valve Replacement.
Boxhammer E; Berezin AE; Paar V; Bacher N; Topf A; Pavlov S; Hoppe UC; Lichtenauer M
J Pers Med; 2022 Apr; 12(4):. PubMed ID: 35455719
[TBL] [Abstract][Full Text] [Related]
12. Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?
Boxhammer E; Mirna M; Bäz L; Bacher N; Topf A; Sipos B; Franz M; Kretzschmar D; Hoppe UC; Lauten A; Lichtenauer M
Life (Basel); 2022 Mar; 12(3):. PubMed ID: 35330140
[TBL] [Abstract][Full Text] [Related]
13. Soluble Urokinase Plasminogen Activator Receptor as a Diagnostic and Prognostic Biomarker in Cardiac Disease.
Velissaris D; Zareifopoulos N; Koniari I; Karamouzos V; Bousis D; Gerakaris A; Platanaki C; Kounis N
J Clin Med Res; 2021 Mar; 13(3):133-142. PubMed ID: 33854652
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic profiling of patients with high gradient aortic stenosis undergoing transcatheter aortic valve replacement.
Haase D; Bäz L; Bekfani T; Neugebauer S; Kiehntopf M; Möbius-Winkler S; Franz M; Schulze PC
Clin Res Cardiol; 2021 Mar; 110(3):399-410. PubMed ID: 33057764
[TBL] [Abstract][Full Text] [Related]
15. Heart-Type Fatty Acid-Binding Protein (H-FABP) and its Role as a Biomarker in Heart Failure: What Do We Know So Far?
Rezar R; Jirak P; Gschwandtner M; Derler R; Felder TK; Haslinger M; Kopp K; Seelmaier C; Granitz C; Hoppe UC; Lichtenauer M
J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936148
[TBL] [Abstract][Full Text] [Related]
16. Disease-specific characteristics of vascular cell adhesion molecule-1 levels in patients with peripheral artery disease.
Edlinger C; Lichtenauer M; Wernly B; Pistulli R; Paar V; Prodinger C; Krizanic F; Thieme M; Kammler J; Jung C; Hoppe UC; Schulze PC; Kretzschmar D
Heart Vessels; 2019 Jun; 34(6):976-983. PubMed ID: 30535754
[TBL] [Abstract][Full Text] [Related]
17. Multi-biomarker analysis in patients after transcatheter aortic valve implantation (TAVI).
Mirna M; Wernly B; Paar V; Jung C; Jirak P; Figulla HR; Kretzschmar D; Franz M; Hoppe UC; Lichtenauer M; Lauten A
Biomarkers; 2018 Dec; 23(8):773-780. PubMed ID: 30041555
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH).
Mirna M; Rohm I; Jirak P; Wernly B; Bäz L; Paar V; Kretzschmar D; Hoppe UC; Schulze PC; Lichtenauer M; Jung C; Franz M
Heart Lung Circ; 2020 Mar; 29(3):337-344. PubMed ID: 31327702
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
